MULTICENTER EVALUATION OF THE PROPOSED QUALITY-CONTROL LIMITS AND INTERPRETIVE ZONE STANDARDS FOR INVITRO SUSCEPTIBILITY TESTING WITH NORFLOXACIN

被引：9

作者：

SHUNGU, DL

TUTLANE, V

GADEBUSCH, HH

机构：

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 1983年 / 18卷 / 04期

关键词：

D O I：

10.1128/JCM.18.4.988-991.1983

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：988 / 991

页数：4

共 10 条

[1] INVITRO ACTIVITY OF MK-0366 AGAINST CLINICAL URINARY PATHOGENS INCLUDING GENTAMICIN-RESISTANT PSEUDOMONAS-AERUGINOSA [J].

DOWNS, J ;

ANDRIOLE, VT ;

RYAN, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :670-672

[2] COMPARISON OF THE ANTIBACTERIAL ACTIVITY OF NORFLOXACIN (MK 0366, AM 715), A NEW ORGANIC-ACID, WITH THAT OF OTHER ORALLY ABSORBED CHEMOTHERAPEUTIC-AGENTS [J].

GADEBUSCH, HH ;

SHUNGU, DL ;

WEINBERG, E ;

CHUNG, SK .

INFECTION, 1982, 10 (01) :41-44

[3] COMPARATIVE ACTIVITIES OF AM-715 AND PIPEMIDIC AND NALIDIXIC ACIDS AGAINST EXPERIMENTALLY INDUCED SYSTEMIC AND URINARY-TRACT INFECTIONS [J].

HIRAI, K ;

ITO, A ;

ABE, Y ;

SUZUE, S ;

IRIKURA, T ;

INOUE, M ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (01) :188-189

[4] NORFLOXACIN (MK-0366, AM-715) - INVITRO ACTIVITY AND CROSS-RESISTANCE WITH OTHER ORGANIC-ACIDS INCLUDING QUALITY-CONTROL LIMITS FOR DISK DIFFUSION TESTING [J].

JONES, RN ;

BARRY, AL .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1983, 1 (02) :165-172

[5] COMPARATIVE INVITRO ACTIVITY OF NORFLOXACIN (MK-0366) AND 10 OTHER ORAL ANTIMICROBIAL AGENTS AGAINST URINARY BACTERIAL ISOLATES [J].

KHAN, MY ;

GRUNINGER, RP ;

NELSON, SM ;

KLICKER, RE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (05) :848-851

[6] INVITRO ACTIVITY OF NORFLOXACIN, A QUINOLINECARBOXYLIC ACID, COMPARED WITH THAT OF BETA-LACTAMS, AMINOGLYCOSIDES, AND TRIMETHOPRIM [J].

NEU, HC ;

LABTHAVIKUL, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (01) :23-27

[7] TENTATIVE INTERPRETIVE STANDARDS FOR DISK DIFFUSION SUSCEPTIBILITY TESTING WITH NORFLOXACIN (MK-0366, AM-715) [J].

SHUNGU, DL ;

WEINBERG, E ;

GADEBUSCH, HH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :256-260

[8] INVITRO ANTI-BACTERIAL ACTIVITY OF NORFLOXACIN (MK-0366, AM-715) AND OTHER AGENTS AGAINST GASTROINTESTINAL-TRACT PATHOGENS [J].

SHUNGU, DL ;

WEINBERG, E ;

GADEBUSCH, HH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) :86-90

[9] NORFLOXACIN DISPOSITION AFTER SEQUENTIALLY INCREASING ORAL DOSES [J].

SWANSON, BN ;

BOPPANA, VK ;

VLASSES, PH ;

ROTMENSCH, HH ;

FERGUSON, RK .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :284-288

[10]

1979, ASM2 NAT COMM CLIN L

← 1 →